2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Nick Leschly$234.4M
Market Cap • 25/07/20242021
(há 3 anos)
2021
(3 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts425
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
TSVTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.